Get the Stockscreener App
34.96
1.66%
0.57
After Hours:
34.96
Vericel Corp stock is traded at $34.96, with a volume of 536.24K.
It is up +1.66% in the last 24 hours and down -5.21% over the past month.
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
See More
Previous Close:
$34.39
Open:
$35.08
24h Volume:
536.24K
Relative Volume:
1.03
Market Cap:
$1.77B
Revenue:
$249.12M
Net Income/Loss:
$7.11M
P/E Ratio:
280.58
EPS:
0.1246
Net Cash Flow:
$-8.30M
1W Performance:
-5.74%
1M Performance:
-5.21%
6M Performance:
+3.83%
1Y Performance:
-31.64%
1-Day Range:
$34.06
$35.30
1-Week Range:
$33.60
$38.49
52-Week Range:
$29.24
$51.93
Vericel Corp Stock (VCEL) Company Profile
Name
Vericel Corp
Sector
Industry
Phone
(734) 930-5555
Address
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
34.96 | 1.74B | 249.12M | 7.11M | -8.30M | 0.1246 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-09-24 | Initiated | Canaccord Genuity | Buy |
| Jun-20-24 | Initiated | TD Cowen | Buy |
| Jan-25-24 | Upgrade | Truist | Hold → Buy |
| Aug-08-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-09-22 | Downgrade | Truist | Buy → Hold |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Jan-11-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Initiated | Stephens | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Oct-09-19 | Initiated | H.C. Wainwright | Buy |
| Feb-28-19 | Downgrade | Needham | Buy → Hold |
| Aug-08-18 | Reiterated | Needham | Buy |
| Jul-16-18 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Apr-04-18 | Initiated | Leerink Partners | Outperform |
| Mar-06-18 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-06-18 | Reiterated | Needham | Buy |
| Mar-05-18 | Reiterated | BTIG Research | Buy |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Mar-13-17 | Reiterated | Needham | Buy |
| Dec-22-16 | Initiated | Piper Jaffray | Overweight |
| Nov-09-16 | Reiterated | Needham | Buy |
| Apr-05-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-11-16 | Upgrade | Needham | Hold → Buy |
View All
Vericel Corp Stock (VCEL) Latest News
Insider Sell: Michael Halpin Sells 10,305 Shares of Vericel Corp (VCEL) - GuruFocus
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion - Investing.com Nigeria
FDA Greenlights Vericel (VCEL) Facility for MACI Production - GuruFocus
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility - The Manila Times
FDA approves new Vericel cell therapy plant to expand cartilage repair - Stock Titan
Sports injury and burn care firm Vericel heads to investor conferences - Stock Titan
Affiliate sale notice for Vericel (NASDAQ: VCEL) — 15,000 shares listed - Stock Titan
VCEL (NASDAQ: VCEL) Form 144 lists vested share sale entries - Stock Titan
H.C. Wainwright raises Vericel stock price target on revenue growth By Investing.com - Investing.com Canada
William Blair Investment Management LLC Buys 1,048,864 Shares of Vericel Corporation $VCEL - MarketBeat
H.C. Wainwright raises Vericel stock price target on revenue growth - Investing.com
Equities Analysts Offer Predictions for Vericel Q4 Earnings - Defense World
HC Wainwright Boosts Vericel (NASDAQ:VCEL) Price Target to $64.00 - Defense World
A Look At Vericel (VCEL) Valuation After Record 2025 Results And Upbeat 2026 Growth Guidance - Yahoo Finance
Should You Buy Vericel Corp (VCEL) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
VCEL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Vericel (NASDAQ:VCEL) Given New $64.00 Price Target at HC Wainwright - MarketBeat
VCEL Analyst Rating: HC Wainwright & Co. Raises Price Target | V - GuruFocus
Vericel Corporation (NASDAQ:VCEL) Q4 2025 Earnings Call Transcript - Insider Monkey
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Breakout Case - ChartMill
Decoding Vericel Corp (VCEL): A Strategic SWOT Insight - GuruFocus
Vericel Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Vericel (NASDAQ:VCEL) Issues Quarterly Earnings Results - MarketBeat
Vericel (VCEL) CEO logs RSU vesting, phantom stock deferral and tax shares - Stock Titan
Vericel (VCEL) CMO logs RSU vesting, phantom stock and tax share withholdings - Stock Titan
RSU vesting boosts Vericel (VCEL) officer Siegal’s shareholding - Stock Titan
Vericel (VCEL) CFO logs RSU vesting and tax withholding share dispositions - Stock Titan
COO at Vericel (VCEL) gains stock through RSU vesting and tax withholding - Stock Titan
Vericel (VCEL) CLO reports RSU vesting, share withholding for taxes - Stock Titan
Vericel Q4 2025 slides: record margins offset by 2026 guidance - Investing.com
Earnings call transcript: Vericel beats Q4 2025 forecasts, stock dips By Investing.com - Investing.com Canada
Earnings call transcript: Vericel beats Q4 2025 forecasts, stock dips - Investing.com India
Vericel Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Vericel Corp (NASDAQ:VCEL) Reports Q4 2025 Earnings In Line, Beats on Profitability - ChartMill
Vericel Corp Ord earnings beat by $0.06, revenue topped estimates - Investing.com Canada
Vericel Corp SEC 10-K Report - TradingView
VERICEL ($VCEL) Releases Q4 2025 Earnings - Quiver Quantitative
Q4 2025 Vericel Corp Earnings Call Transcript - GuruFocus
Earnings Breakdown: Vericel Q4 - Benzinga
Vericel Corporation Reports Fourth Quarter and Full-Year 2025 Financial Results - TradingView
Strong 2025 growth at Vericel (NASDAQ: VCEL) with $276.3M revenue - Stock Titan
Vericel Corporation Reports 21% MACI Revenue Growth and 59% Increase in Net Income for Full-Year 2025 - Quiver Quantitative
Sports medicine firm Vericel lifts 2025 revenue to $276M, profit up 59% - Stock Titan
VCEL Technical Analysis & ETF Price Forecast - Intellectia AI
Retail Trends: Can Vericel Corporation beat the S P 500July 2025 Price Swings & Stock Market Timing Techniques - baoquankhu1.vn
Vericel faces earnings test as profitability targets loom - Investing.com South Africa
What are the future prospects of Vericel CorporationTrade Volume Report & Smart Allocation Stock Tips - baoquankhu1.vn
What are Vericel Corporation’s earnings expectations2025 Geopolitical Influence & AI Powered Trade Plan Recommendations - mfd.ru
Vericel (VCEL) CEO receives large new stock option and RSU grants - Stock Titan
Vericel (VCEL) CLO awarded 35,000 options and 14,000 RSUs plus RSU vesting - Stock Titan
Vericel (VCEL) CFO receives new equity awards and RSU vesting - Stock Titan
Vericel Corp Stock (VCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
6.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):